Lectenz Bio in News and Media

May 1, 2018 0 0

Research Scientist Matthew Saunders presented a poster and gave a CYTO Innovation talk on GlycoSenseTM: A Rapid Method for Monitoring In...

April 25, 2018 0 0

Interim CEO and CSO Lori Yang presented two posters and gave a talk on GlycoSenseTM: A Rapid Method for Monitoring In Vitro Glycoengineering...

April 23, 2018 1 0

Director of Operations Sean Wu presented a poster and gave a talk on sialoglycoconjugate detection and enrichment products. Learn more about...

April 10, 2018 0 0

The Lectenz Bio team is excited to announce the approval of its patent for the Lectenz® platform technology. This paves the way for more...

January 15, 2018 0 0

The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic...

September 1, 2017 0 0

The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply the...

August 1, 2017 0 0

Lectenz Bio receives a U01 from the NIH Common Fund Glycoscience program to further develop GlycoSenseTM technology. Lectenz Bio receives an SBIR...

June 19, 2017 0 0

Dr. Lori Yang, co-Founder and CSO of Lectenz Bio, will be a featured panelist at San Diego Startup Week on June 20th. Dr. Yang will share about...

June 16, 2017 0 0

Prof. Robert J. Woods, President and co-Founder, and collaborators reported in PLoS Pathogens on Thursday, June 15th that three mutations switch...

March 28, 2017 0 0

The Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This expands the...

March 8, 2017 0 0

Lectenz Bio’s Chief Scientific Officer and co-founder Lori Yang was recently interviewed by JLabs for her work on International...

October 12, 2016 0 0

Lectenz Bio team was selected to participate as semi-finalists for the 2016 Thermo Fisher Scientific Innovation Day. This unique program is set up...